South Africa · Delayed Price · Currency is ZAR · Price in ZAc Life Healthcare Group Holdings Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 2.4% year-over-year with improved EBITDA margin and operating profit, despite a setback from a medical scheme curatorship. Asset optimization, cost savings, and expansion projects are progressing, with strong complementary services growth and a healthy balance sheet.
Fiscal Year 2025
-
Strong operational and financial results with 6% revenue growth, robust cash generation, and increased dividends. Asset optimization and integration of acquired businesses remain key focus areas, with significant cost savings and margin improvements targeted over the next three years.
-
Revenue grew 8.1% and normalized EPS rose 9.1% year-over-year, with strong cash flow and a 10.5% higher interim dividend. Strategic expansions and asset optimization continue, while the LMI transaction is set to deliver significant shareholder returns.
Fiscal Year 2024
-
Group revenue rose 12.7% year-over-year, driven by strong growth in Life Molecular Imaging and solid performance in Southern Africa. ZAR 10.6 billion was returned to shareholders, and a robust balance sheet supports ongoing expansion and efficiency initiatives.